334 related articles for article (PubMed ID: 21205929)
1. Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice.
Ramirez-Herrick AM; Mullican SE; Sheehan AM; Conneely OM
Blood; 2011 Mar; 117(9):2681-90. PubMed ID: 21205929
[TBL] [Abstract][Full Text] [Related]
2. The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms.
Wenzl K; Troppan K; Neumeister P; Deutsch AJ
Curr Drug Targets; 2015; 16(1):38-46. PubMed ID: 25410408
[TBL] [Abstract][Full Text] [Related]
3. Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia.
Mullican SE; Zhang S; Konopleva M; Ruvolo V; Andreeff M; Milbrandt J; Conneely OM
Nat Med; 2007 Jun; 13(6):730-5. PubMed ID: 17515897
[TBL] [Abstract][Full Text] [Related]
4. NR4A1 and NR4A3 restrict HSC proliferation via reciprocal regulation of C/EBPα and inflammatory signaling.
Freire PR; Conneely OM
Blood; 2018 Mar; 131(10):1081-1093. PubMed ID: 29343483
[TBL] [Abstract][Full Text] [Related]
5. [Precursors of acute leukemia: myelodysplastic syndromes and myeloproliferative neoplasms].
Kreipe HH
Pathologe; 2011 Nov; 32 Suppl 2():271-6. PubMed ID: 22033685
[TBL] [Abstract][Full Text] [Related]
6. JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells.
Celik H; Koh WK; Kramer AC; Ostrander EL; Mallaney C; Fisher DAC; Xiang J; Wilson WC; Martens A; Kothari A; Fishberger G; Tycksen E; Karpova D; Duncavage EJ; Lee Y; Oh ST; Challen GA
Cancer Cell; 2018 Nov; 34(5):741-756.e8. PubMed ID: 30423295
[TBL] [Abstract][Full Text] [Related]
7. Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53.
Kanagal-Shamanna R; Bueso-Ramos CE; Barkoh B; Lu G; Wang S; Garcia-Manero G; Vadhan-Raj S; Hoehn D; Medeiros LJ; Yin CC
Cancer; 2012 Jun; 118(11):2879-88. PubMed ID: 22038701
[TBL] [Abstract][Full Text] [Related]
8. Nr4a1 and Nr4a3 Reporter Mice Are Differentially Sensitive to T Cell Receptor Signal Strength and Duration.
Jennings E; Elliot TAE; Thawait N; Kanabar S; Yam-Puc JC; Ono M; Toellner KM; Wraith DC; Anderson G; Bending D
Cell Rep; 2020 Nov; 33(5):108328. PubMed ID: 33147449
[TBL] [Abstract][Full Text] [Related]
9. NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas.
Deutsch AJ; Rinner B; Wenzl K; Pichler M; Troppan K; Steinbauer E; Schwarzenbacher D; Reitter S; Feichtinger J; Tierling S; Prokesch A; Scheideler M; Krogsdam A; Thallinger GG; Schaider H; Beham-Schmid C; Neumeister P
Blood; 2014 Apr; 123(15):2367-77. PubMed ID: 24553175
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional Profiling of Monocytes Deficient in Nuclear Orphan Receptors
Phelan DE; Shigemura M; Aldhafiri S; Mota C; Hall TJ; Sznajder JI; Murphy EP; Crean D; Cummins EP
Front Immunol; 2021; 12():676644. PubMed ID: 34248958
[TBL] [Abstract][Full Text] [Related]
11. Role of local muscle contractile activity in the exercise-induced increase in NR4A receptor mRNA expression.
Kawasaki E; Hokari F; Sasaki M; Sakai A; Koshinaka K; Kawanaka K
J Appl Physiol (1985); 2009 Jun; 106(6):1826-31. PubMed ID: 19359610
[TBL] [Abstract][Full Text] [Related]
12. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
13. The orphan nuclear receptor Nor1/Nr4a3 is a negative regulator of β-cell mass.
Close AF; Dadheech N; Villela BS; Rouillard C; Buteau J
J Biol Chem; 2019 Mar; 294(13):4889-4897. PubMed ID: 30696767
[TBL] [Abstract][Full Text] [Related]
14. NR4A gene expression is dynamically regulated in the ventral tegmental area dopamine neurons and is related to expression of dopamine neurotransmission genes.
Eells JB; Wilcots J; Sisk S; Guo-Ross SX
J Mol Neurosci; 2012 Mar; 46(3):545-53. PubMed ID: 21932041
[TBL] [Abstract][Full Text] [Related]
15. The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss.
Veum VL; Dankel SN; Gjerde J; Nielsen HJ; Solsvik MH; Haugen C; Christensen BJ; Hoang T; Fadnes DJ; Busch C; Våge V; Sagen JV; Mellgren G
Int J Obes (Lond); 2012 Sep; 36(9):1195-202. PubMed ID: 22143616
[TBL] [Abstract][Full Text] [Related]
16. Genome Wide Mapping of NR4A Binding Reveals Cooperativity with ETS Factors to Promote Epigenetic Activation of Distal Enhancers in Acute Myeloid Leukemia Cells.
Duren RP; Boudreaux SP; Conneely OM
PLoS One; 2016; 11(3):e0150450. PubMed ID: 26938745
[TBL] [Abstract][Full Text] [Related]
17. The nuclear orphan receptors NR4A as therapeutic target in cancer therapy.
Deutsch AJ; Angerer H; Fuchs TE; Neumeister P
Anticancer Agents Med Chem; 2012 Nov; 12(9):1001-14. PubMed ID: 22583411
[TBL] [Abstract][Full Text] [Related]
18. Stress and glucocorticoid regulation of NR4A genes in mice.
Helbling JC; Minni AM; Pallet V; Moisan MP
J Neurosci Res; 2014 Jul; 92(7):825-34. PubMed ID: 24753204
[TBL] [Abstract][Full Text] [Related]
19. Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies.
Puda A; Milosevic JD; Berg T; Klampfl T; Harutyunyan AS; Gisslinger B; Rumi E; Pietra D; Malcovati L; Elena C; Doubek M; Steurer M; Tosic N; Pavlovic S; Guglielmelli P; Pieri L; Vannucchi AM; Gisslinger H; Cazzola M; Kralovics R
Am J Hematol; 2012 Mar; 87(3):245-50. PubMed ID: 22190018
[TBL] [Abstract][Full Text] [Related]
20. The NR4A orphan nuclear receptors: mediators in metabolism and diseases.
Ranhotra HS
J Recept Signal Transduct Res; 2015 Apr; 35(2):184-8. PubMed ID: 25089663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
